GangaGen Secures Additional US$7.9M from CARB-X for Pre-clinical Development
December 20, 2024
GangaGen is pleased to announce today that it has secured the third installment of its phased funding grant from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), a global non-profit